Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 604 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cardiol Therapeutics Inc.
Market Cap
$152.16M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$151.70M
Operating Margin
-54.46%
TTM Avg
-76.53%
3Y Avg
-68.82%
5Y Avg
-55.26%
Market Cap
$151.05M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$153.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.75%
Market Cap
$147.97M
Operating Margin
-9.35%
TTM Avg
-5.78%
3Y Avg
-14.39%
5Y Avg
-45.18%
Market Cap
$154.71M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-615.66%
Market Cap
$155.86M
Operating Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$146.71M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$157.47M
Operating Margin
-8.45%
TTM Avg
-10.66%
3Y Avg
-19.64%
5Y Avg
-13.31%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiol Therapeutics Inc. (CRDL) | $152.16M | 0.00% | 0.00% | 0.00% | 0.00% |
| Codexis, Inc. (CDXS)vs › | $151.70M | -54.46% | -76.53% | -68.82% | -55.26% |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Minerva Neurosciences, Inc. (NERV)vs › | $153.61M | 0.00% | 0.00% | 0.00% | 0.75% |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | -9.35% | -5.78% | -14.39% | -45.18% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $154.71M | 0.00% | 0.00% | 0.00% | -615.66% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | 0.00% | 0.00% | 0.00% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $146.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Inogen, Inc. (INGN)vs › | $157.47M | -8.45% | -10.66% | -19.64% | -13.31% |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.65M | -239.78% | -210.59% | -1665.90% | -1977.59% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -8155.55% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
